- Kalantar-Zadeh, Kamyar;
- The International Federation of Kidney Foundation – World Kidney Alliance, Transplantation;
- Li, Philip Kam-Tao;
- Tantisattamo, Ekamol;
- Kumaraswami, Latha;
- Liakopoulos, Vassilios;
- Lui, Siu-Fai;
- Ulasi, Ifeoma;
- Andreoli, Sharon;
- Balducci, Alessandro;
- Dupuis, Sophie;
- Harris, Tess;
- Hradsky, Anne;
- Knight, Richard;
- Kumar, Sajay;
- Ng, Maggie;
- Poidevin, Alice;
- Saadi, Gamal;
- Tong, Allison;
- Department of Medicine and Therapeutics, Carol Richard Yu PD Research Centre;
- Division of Nephrology, Hypertension and Kidney Transplantation;
- Tanker Foundation, Chennai;
- Division of Nephrology and Hypertension, Department of Internal Medicine;
- Hong Kong Kidney Foundation and the International Federation of Kidney Foundations – World Kidney Alliance, The Jockey Club School of Public Health and Primary Care;
- Renal Unit, Department of Medicine;
- James Whitcomb Riley Hospital for Children, Indiana University School of Medicine;
- Italian Kidney Foundation, Rome;
- World Kidney Day Office, Brussels;
- Polycystic Kidney Disease Charity, London;
- American Association of Kidney Patients, Tampa;
- Hong Kong Kideny Foundation, Hong Kong;
- Nephrology Unit, Department of Internal Medicine;
- Sydney School of Public Health, The University of Sydney
Living with chronic kidney disease (CKD) is associated with hardships for patients and their care-partners. Empowering patients and their care-partners, including family members or friends involved in their care, may help minimize the burden and consequences of CKD related symptoms to enable life participation. There is a need to broaden the focus on living well with kidney disease and re-engagement in life, including an emphasis on patients being in control. The World Kidney Day (WKD) Joint Steering Committee has declared 2021 the year of “Living Well with Kidney Disease” to increase education and awareness on the important goal of patient empowerment and life participation. This calls for the development and implementation of validated patient-reported outcome measures to assess and address areas of life participation in routine care. It could be supported by regulatory agencies as a metric for quality care or to support labelling claims for medicines and devices. Funding agencies could establish targeted calls for research that address the priorities of patients. Patients with kidney disease and their care-partners should feel supported to live well through concerted efforts by kidney care communities including during pandemics. In the overall wellness program for kidney disease patients, the need for prevention should be reiterated. Early detection with a prolonged course of wellness despite kidney disease, after effective secondary and tertiary prevention programs, should be promoted. WKD 2021 continues to call for increased awareness of the importance of preventive measures throughout populations, professionals and policy makers applicable to both developed and developing countries.